The term lung cancer is usually used to describe any of several types of primary tumors arising in the lung; common histological types include adenocarcinoma, squamous cell carcinoma, large cell carcinoma, bronchoalveolar cancer, and small-cell lung cancer. Taken together, lung cancer is the most common non-AIDS-defining malignancy in HIV-infected individuals. Lung cancer risk appears to be two to five times greater in the HIV-infected persons compared to the general population, and most epidemiological studies find that the risk remains high even after adjusting for other factors like smoking intensity and duration. Often these patients present with advanced disease at a younger age but may have comparable survival compared with similarly matched lung cancer patients without HIV infection. Smoking cessation is the most effective preventive strategy.
The advent of highly active antiretroviral therapy (HAART) (Antiretroviral Medications, Care and Treatment),...
KeywordsLung Cancer Smoking Cessation Nicotine Replacement Therapy Lung Cancer Risk Lung Cancer Mortality
- D’Jaen GA, Pantanowitz L, Bower M, Buskin S, Neil N, Greco EM, Cooley TP, Henry D, Stem J, Dezube BJ, Stebbing J, Aboulafia DM. Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. Clin Lung Cancer. 2010;11:396–404.PubMedCrossRefGoogle Scholar
- Hooker CM, Meguid RA, Hulbert A, Taylor JT, Shin J, Wrangle J, Rodgers K, Lee B, Laskshmanan S, Brown T, Meneshian A, Sussman M, Keruly J, Moore RD, Yang SC, Brock MV. Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer. Ann Thorac Surg. 2012;93:405–12.PubMedCentralPubMedCrossRefGoogle Scholar
- Makinson A, Tenon JC, Eymard-Duvernay S, Pujol JL, Allavena C, Cuzin L, Poizot-Martin I, de la Tribonnière X, Cabié A, Pugliese P, Reynes J, Le Moing V. Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study. J Thorac Oncol. 2011;6:1022–9.PubMedCrossRefGoogle Scholar
- Pakkala S, Ramalingam SS. Lung cancer in HIV-positive patients. J Thorac Oncol. 2010;5:1864–71.Google Scholar
- Rengan R, Mitra N, Liao K, Armstrong K, Vachani A. Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study.Lancet Oncol. 2012;13:1203–9Google Scholar